Liang Cheng, President of the International Society of Urological Pathology (ISUP), recently highlighted a new article in European Urology. Co-authored with Irbaz Riaz and Rodolfo Montironi, “Promise of Genomic AI Tools in Precision Oncology” examines the potential of genomic classifiers and histopathology-only AI in enhancing prognostic insights in oncology. While these tools have shown promise, the authors emphasize that current evidence mainly derives from retrospective studies rather than robust prospective trials. The article underscores the necessity for rigorous validation to ensure these genomic and AI tools evolve from promising concepts to reliable clinical resources. For professionals in oncology and pathology seeking to understand the implications of AI in risk stratification for prostate cancer, this research serves as an essential read. Discover more insights from Liang Cheng on OncoDaily, and enhance your understanding of AI applications in cancer treatment.
Read the full article in European Urology.
